Zhengye Biotechnology Holding Limited Cost of Revenue
Zhengye Biotechnology Holding Limited (ZYBT) reported Cost of Revenue of CNY 92.49 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-04-28
CNY
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | 92.49M CNY 20-F · filed 2026-04-28 | |
| 2025-06-30 | 42.94M CNY 6-K · filed 2025-12-12 | |
| 2024-12-31 | 95.06M CNY 20-F · filed 2026-04-28 | |
| 2024-06-30 | 41.73M CNY 6-K · filed 2025-12-12 | |
| 2023-12-31 | 94.14M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 112.39M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | $13.23M 20-F · filed 2026-04-28 | |
| 2025-06-30 | $5.99M 6-K · filed 2025-12-12 | |
| 2024-12-31 | $13.02M 20-F · filed 2025-07-03 |